National
U.S. envoy meets Ugandan leaders over anti-gay bill
State Dept. reiterates concerns over legislation
The top U.S. diplomat in Africa met over the weekend with leaders in Uganda to express concerns about an anti-gay bill pending before the country’s parliament that could be headed for a vote as soon as this week, according to the State Department.
Victoria Nuland, a State Department spokesperson, said during a daily briefing Monday that Assistant Secretary of State for African Affairs Johnnie Carson met with high-profile leaders in Uganda “over the weekend” and raised concerns about the bill, which among other things would punish homosexual acts with life in prison. The questioning was initiated by the Washington Blade.
“As we have regularly said, we call on the parliament of Uganda to look very carefully at this because Uganda’s own Human Rights Council has made clear that if this were to pass, it would put the country out of compliance with its own international human rights obligations,” Nuland said. “And so, Assistant Secretary Carson had a chance to make that point again and our strong opposition to this, to the president, to the parliament and to key decision makers in Uganda.”
Nuland also affirmed media reports from last week that the legislation has passed out of the Legal & Parliamentary Affairs Committee, saying, “Our understanding is that a version of the bill has now passed the committee in Uganda.”
Carson spoke with these leaders on the same Africa trip where he’s meeting with Museveni as well as other leaders in the area in an attempt to end violence in the eastern Democratic Republic of Congo.
It wouldn’t be the first time Carson has raised concerns about the bill with Uganda President Yoweri Museveni. In 2009, the Washington Blade reported that Carson met with Museveni about the bill and later had conversations about it on the phone. On both occasions, the State Department said Museveni had pledged to block the bill from becoming law and would veto it if it came to his desk.
Nuland later said Carson met with Uganda Parliament Speaker Rebecca Kadaga, who’s reportedly been a chief advocate of the anti-gay bill, although it’s unclear whether the meeting was just with her or a larger group of Ugandan leaders. Kadaga is quoted in Reuters earlier this month as saying, “Ugandans want that law as a Christmas gift. They have asked for it and we’ll give them that gift.”
Homosexual acts are already illegal in Uganda, but the proposed bill would expand existing law to institute life imprisonment for those found guilty of homosexuality in addition to prohibiting public support for LGBT rights. According to Sexual Minorities Uganda, parents and teachers would be fined if they don’t report gay children and students and landlords who rent to gay people would be punished with jail time.
The legislation — colloquially known in the United States as the “Kill the Gays” bill — became infamous in the international community after its introduction in 2009 for including a provision that would institute the death penalty for “aggravated homosexuality.”
But it’s unclear whether this provision remains in the legislation. Early on Friday, BBC News Africa reported that a legislative committee had “endorsed” the legislation, but had dropped the death penalty provision. Previous reports had indicated the death penalty provision has been dropped, and yet that language was found in the bill.
Nuland told the Blade the State Department is uncertain about whether the death penalty provision has been dropped from the bill because the committee has yet to make its report on the bill public.
“I don’t know that we have actually seen the version that passed committee,” Nuland said. “They’ve been a little bit close hold about this, partly because there’s been so much controversy in the international community. So our concern is about any criminalization of homosexuality, obviously.”
Some countries, such as Britain and Sweden, have threatened to cut foreign aid to Uganda if this bill becomes law. U.S. Ambassador to Uganda Scott H. DeLisi was quoted in a Ugandan newspaper as saying the United States has “decided to continue giving aid to Uganda,” but that was in response to misuse of foreign aid and not the anti-gay bill.
Nuland declined to directly answer a question from the Blade about whether the State Department was considering whether to cut foreign aid from Uganda if the legislation becomes law.
“I’m not going to get into any hypothetical situations,” Nuland said. “Our focus now is on raising awareness of the concerns within Uganda about this bill, so we don’t get to that stage.”
Asked by another reporter about whether a pledge to cut aid would be “a good, strong point to make” if the United States opposes the bill, Nuland said she won’t “make prospective points from the podium here about where we might go if this bill passes.”
Nuland refocused attention to talks within the country, saying, “I think there is a very intense conversation going on inside Uganda about this, and the far better course of action would be for the bill not to pass.”
Pressed further on the prospects of cutting aid by yet another reporter, Nuland signaled those talks should happen at a later time, saying, “Again, we’re at a relatively preliminary stage here where you’ve had one committee pass this. There is room for those kinds of conversations. Our first focus at the moment is on getting reconsideration of this.”
Nuland also addressed questions about the United States denying Kadaga a visa. The spokesperson said she’s not aware of a visa question and said the State Department can’t generally talk about such issues.
A transcript of the exchange between Nuland and reporters follows:
Q: Yeah, I have a question on Uganda, actually. There’s an anti-homosexuality bill that’s making its way through the legislature right there. What is the State Department’s current assessment of where that bill is and if that’s going to be headed toward a vote anytime soon?
MS. NULAND: Again, Assistant Secretary Carson was also in Uganda over the weekend. He had a chance to raise again our concerns about this issue, which we’ve been very vocal about. Our understanding is that a version of the bill has now passed a committee in Uganda. As we have regularly said, we call on the parliament in Uganda to look very carefully at this, because Uganda’s own human rights council has made clear that if this were to pass, it would put the country out of compliance with its own international human rights obligations. And so Assistant Secretary Carson had a chance to make that point again and our strong opposition to this, to the president, to the parliament, and to key decision makers in Uganda.
Q: And there was – and once the bill had a provision that would institute the death penalty for homosexual acts. As far as the State Department knows, has that provision been removed or is it still in the bill?
MS. NULAND: Again, I don’t know that we have actually seen the version that passed committee. They’ve been a little bit close hold about this, partly because there’s been so much controversy in the international community. So our concern is about any criminalization of homosexuality, obviously.
Q: And one last question. Some countries, Britain and Sweden, have threatened to cut foreign aid to Uganda if this bill becomes law. Is there any consideration in the U.S. Administration to cut foreign aid to Uganda if that bill becomes law?
MS. NULAND: Again, I’m not going to get into any hypothetical situations. Our focus now is on raising awareness of the concerns within Uganda about this bill so that we don’t get to that stage.
…
Q: Wait, wait one second. I don’t understand why you wouldn’t – don’t you think that would be a pretty strong point to make to the Ugandans if you think this is a bad idea that you would say, hey, you can go ahead and do this, but it’s not only going to not only violate your international commitments but it’s also going to jeopardize American assistance? Why would you —
MS. NULAND: Again, I’m not to make prospective points from the podium here about where we might go if this bill passes. I think there is a very intense conversation going on inside Uganda about this, and the far better course of action would be for the bill not to pass.
Q: And isn’t that what happened a couple of years ago when the harsh bill was put up and there were active threats from not just the U.K. but also the United States that if this bill were to pass, aid would be cut? And that was part of why the bill was tabled, no?
MS. NULAND: Again, we’re at a relatively preliminary stage here where you’ve had one committee pass this. There is room for those kinds of conversations. Our first focus at the moment is on getting reconsideration of this.
…
Q: On this, Toria. Did Secretary Carson meet with the speaker of the parliament?
MS. NULAND: My understanding is he did see the speaker of the parliament, whether it was in a larger group or whether it was a distinct meeting that he did, yes.
Q: But he – so he made that point directly to her?
MS. NULAND: Yes, he did.
Q: Okay. Can you – do you have in your guidance there the ability to deny the reports that built up over the long weekend that the United States had denied her a visa?
MS. NULAND: Well, obviously we don’t talk about visa issuance one way or the other, so I don’t have any information about it one way or the other. But I frankly hadn’t heard that there was a visa question involved in this at all.
Q: There was one. And the parliament then issued its own statement which was slightly ambiguous, but it sounded like they were trying to say that, no, you guys had not denied her a visa.
MS. NULAND: I’m not aware of any visa issues. But in general, as you know, we can’t talk about these things.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
